In equities, shares of Teva Pharmaceuticals ( TEVA ) were 12% lower pre-bell after the generic drug maker reported mixed Q4 results and issued a weaker-than-expected outlook. US stock futures pointed north Wednesday ahead of the release of the latest reading on US inflation, while recent presidential comments on the ongoing US-China trade talks also drove market optimism. President Donald Trump signaled he would allow more flexibility on the trade-deal deadline if the two sides were making enough progress.